Ian Cummins explores a recent international systematic review and meta-analysis, which highlights ethnic variations in compulsory detention under the Mental Health Act.
[read the full story...]
David Shiers and Peter Byrne summarise the new SCIMITAR+ trial out today in The Lancet Psychiatry, which evaluates a bespoke smoking cessation intervention for people with severe mental illness.
[read the full story...]
Robyn Murphy summarises an RCT that compares the effectiveness and cost-effectiveness of an intensive community supported discharge service versus treatment as usual for adolescents with psychiatric emergencies.
[read the full story...]
Simon Bradstreet welcomes the positive findings of the REFOCUS-PULSAR trial, which evaluated recovery-oriented practice training in specialist mental health care.
[read the full story...]
John Baker explores a systematic review of compulsory community treatment to reduce readmission to hospital and increase engagement with community care in people with mental illness.
[read the full story...]
Dean Connolly is impressed by a recent systematic review and network meta-analysis, which compares the efficacy and tolerability of medication for ADHD in children, young people and adults.
[read the full story...]
Mark Brown mulls over a new systematic review on factors affecting the implementation of digital health interventions for people with psychosis or bipolar disorder, and their family and friends.
[read the full story...]
Linda Gask is encouraged by the findings of a new high quality RCT (the DRD study), which compares preventive cognitive therapy while tapering antidepressants versus maintenance antidepressant treatment versus their combination in the prevention of depressive relapse or recurrence.
[read the full story...]
John Torous, Editor of the Journal of Medical Internet Research, considers the top 10 digital mental health research questions that are announced today by the NIHR Mindtech James Lind Alliance Priority Setting Partnership on Digital Mental Health.
[read the full story...]
Elwira Lubos summarises the recent ATLAS RCT of antipsychotic treatment for very late-onset schizophrenia-like psychosis, which provides evidence for the effectiveness of a very low dose of Amisulpride (100 mg).
[read the full story...]
